E
Elicio Therapeutics, Inc. (ELTX)
NCM – Real Time Price. Currency in USD
4.00
+0.25 (6.67%)
At close: Jun 26, 2026, 4:00 PM EDT
4.00
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:21 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
4.00
+0.25 (6.67%)
At close: Jun 26, 2026, 4:00 PM EDT
4.00
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:21 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $14.9M significantly exceed its total debt $14.3M, ensuring strong financial flexibility
Total current assets $16.2M exceed Total current liabilities $7.2M, highlighting excellent liquidity
Debt-to-equity ratio (-10.0) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-26.0x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$11.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.24 | 6.05 | 10 | |
| Quick ratio | 2.24 | 5.63 | 10 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.63 | 1.04 | 3.0 | |
| Interest coverage | -26.05 | -16.91 | 1.0 | |
| Weighted average score | 5.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -1M | -1M | -1M | -1M | -1M |
| Operating Income | -24M | -36M | -45M | -38M | -38M |
| Net Income | -28M | -35M | -52M | -40M | -40M |
| EBITDA | -23M | -35M | -44M | -37M | -36M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 18.63 | 5.0 |
| Next quarter | N/A | 17 | 5.0 |
| Current year | N/A | 17.36 | 5.0 |
| Next year | N/A | -23.6 | 1.0 |
| Weighted average score | 4.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -53.18 | -44.43 | -70.91 | 3.3 |
| Y/Y | 999 | -5.47 | 25.29 | -15.07 | 5.5 |
| 3y average | 999 | -16.14 | 39.11 | -18.78 | 5.5 |
| 5y average | 756.01 | 6.34 | 47.56 | -26.13 | 6.5 |
| Weighted average score | 5.2 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |